| Laura Diane Stearman, MD | |
|
4833 Integris Pkwy, Suite 200, Edmond, OK 73034-8864 | |
| (405) 657-3825 | |
| (405) 657-3824 |
| Full Name | Laura Diane Stearman |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 22 Years |
| Location | 4833 Integris Pkwy, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962514455 | NPI | - | NPPES |
| 200201080A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 26343 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeside Women's Hospital, A Member Of Integris He | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urogynecology Of Oklahoma, Pllc | 6507253523 | 3 |
News Archive
Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.
Boston Medical Center has implemented a social determinants of health screener for primary care patients in order to better identify and address patients' unmet social needs.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
In a recent study, researchers conducted a nasopharyngeal microbiota profiling parallelism in an effort to analyze microbiota variations in COVID-19 patients.
Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel's most popular sunscreen, Dr. Fischer ULTRASOL, in the United States.
› Verified 7 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.
Boston Medical Center has implemented a social determinants of health screener for primary care patients in order to better identify and address patients' unmet social needs.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
In a recent study, researchers conducted a nasopharyngeal microbiota profiling parallelism in an effort to analyze microbiota variations in COVID-19 patients.
Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel's most popular sunscreen, Dr. Fischer ULTRASOL, in the United States.
› Verified 7 days ago
| Entity Name | Urogynecology Of Oklahoma, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629726716 PECOS PAC ID: 6507253523 Enrollment ID: O20220421001865 |
News Archive
Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.
Boston Medical Center has implemented a social determinants of health screener for primary care patients in order to better identify and address patients' unmet social needs.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
In a recent study, researchers conducted a nasopharyngeal microbiota profiling parallelism in an effort to analyze microbiota variations in COVID-19 patients.
Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel's most popular sunscreen, Dr. Fischer ULTRASOL, in the United States.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Diane Stearman, MD 5300 N Independence Ave, Suite 280, Oklahoma City, OK 73112-5556 Ph: (405) 657-3825 | Laura Diane Stearman, MD 4833 Integris Pkwy, Suite 200, Edmond, OK 73034-8864 Ph: (405) 657-3825 |
News Archive
Researchers at the Dana-Farber Cancer Institute in Boston have identified a new type of cell in mice that dampens the immune system and protects the animal's own cells from immune system attack.
Boston Medical Center has implemented a social determinants of health screener for primary care patients in order to better identify and address patients' unmet social needs.
New IMBRUVICA (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc) during the 56th American Society of Hematology Annual Meeting suggests that IMBRUVICA demonstrates anti-tumor activity both as a single-agent and as combination therapy in heavily pre-treated patients with relapsed or relapsed/refractory multiple myeloma (MM).
In a recent study, researchers conducted a nasopharyngeal microbiota profiling parallelism in an effort to analyze microbiota variations in COVID-19 patients.
Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel's most popular sunscreen, Dr. Fischer ULTRASOL, in the United States.
› Verified 7 days ago
Charles A Mcwilliams, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 14101 N Eastern Ave, Suite C, Edmond, OK 73013 Phone: 405-340-1279 Fax: 405-340-1605 | |
Dr. Motoo Araki, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1919 E 2nd St Apt 271, Edmond, OK 73034 Phone: 786-877-4739 Fax: 405-271-6900 | |
John P Ross, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 14104 N. Eastern Ave. Ste. E, Edmond, OK 73013 Phone: 405-340-1279 Fax: 405-216-5089 |